Alan Pourpak

905 total citations
11 papers, 533 citations indexed

About

Alan Pourpak is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Alan Pourpak has authored 11 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Alan Pourpak's work include Cancer therapeutics and mechanisms (2 papers), Chemical Synthesis and Analysis (2 papers) and Marine Sponges and Natural Products (2 papers). Alan Pourpak is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Chemical Synthesis and Analysis (2 papers) and Marine Sponges and Natural Products (2 papers). Alan Pourpak collaborates with scholars based in United States and China. Alan Pourpak's co-authors include Stephan W. Morris, Vijay Gokhale, Kexiao Guo, Laurence H. Hurley, Daekyu Sun, Rongshi Li, Thomas R. Webb, Xiaoli Cui, Qin Jiang and Robert T. Dorr and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Alan Pourpak

11 papers receiving 530 citations

Peers

Alan Pourpak
Martin Golkowski United States
Jenny Chik Australia
Michael Burkard United States
C.C. Milburn United Kingdom
Lawrence Andrade United States
E. A. Partridge United Kingdom
Lynn Wood United Kingdom
Martin Golkowski United States
Alan Pourpak
Citations per year, relative to Alan Pourpak Alan Pourpak (= 1×) peers Martin Golkowski

Countries citing papers authored by Alan Pourpak

Since Specialization
Citations

This map shows the geographic impact of Alan Pourpak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Pourpak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Pourpak more than expected).

Fields of papers citing papers by Alan Pourpak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Pourpak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Pourpak. The network helps show where Alan Pourpak may publish in the future.

Co-authorship network of co-authors of Alan Pourpak

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Pourpak. A scholar is included among the top collaborators of Alan Pourpak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Pourpak. Alan Pourpak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sun, Yi, Jyh-Rong Chao, Wu Xu, et al.. (2017). MLF1 is a proapoptotic antagonist of HOP complex-mediated survival. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1864(4). 719–727. 7 indexed citations
2.
Pourpak, Alan, et al.. (2011). Design, synthesis and initial biological evaluation of a novel pladienolide analog scaffold. MedChemComm. 2(9). 904–904. 19 indexed citations
3.
Meyers, Ross O., Joshua D. Lambert, Nicole Hajicek, et al.. (2009). Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid. Bioorganic & Medicinal Chemistry Letters. 19(16). 4752–4755. 18 indexed citations
4.
Lagisetti, Chandraiah, Alan Pourpak, Qin Jiang, et al.. (2009). Synthetic mRNA Splicing Modulator Compounds with in Vivo Antitumor Activity. Journal of Medicinal Chemistry. 52(22). 6979–6990. 56 indexed citations
5.
Li, Rongshi, Alan Pourpak, & Stephan W. Morris. (2009). Inhibition of the Insulin-like Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy Approach. Journal of Medicinal Chemistry. 52(16). 4981–5004. 105 indexed citations
6.
Lagisetti, Chandraiah, Alan Pourpak, Qin Jiang, et al.. (2008). Antitumor Compounds Based on a Natural Product Consensus Pharmacophore. Journal of Medicinal Chemistry. 51(19). 6220–6224. 52 indexed citations
7.
Pourpak, Alan, Terry H. Landowski, & Robert T. Dorr. (2007). Ethonafide-Induced Cytotoxicity Is Mediated by Topoisomerase II Inhibition in Prostate Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 321(3). 1109–1117. 17 indexed citations
9.
Guo, Kexiao, et al.. (2007). Formation of Pseudosymmetrical G-Quadruplex and i-Motif Structures in the Proximal Promoter Region of the RET Oncogene. Journal of the American Chemical Society. 129(33). 10220–10228. 229 indexed citations
10.
Pourpak, Alan, Ross O. Meyers, Betty K. Samulitis, et al.. (2006). Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in mice. Anti-Cancer Drugs. 17(10). 1179–1184. 11 indexed citations
11.
Pourpak, Alan, Robert T. Dorr, Ross O. Meyers, Marianne Broome Powell, & Steven P. Stratton. (2006). Cytotoxic activity of Apomine is due to a novel membrane-mediated cytolytic mechanism independent of apoptosis in the A375 human melanoma cell line. Investigational New Drugs. 25(2). 107–114. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026